Search

everythinglearnresearchcommunity

for

Search:↓

Upadacitinib is safe and effective for treating alopecia areata and atopic dermatitis in children.

A Korean woman with complete hair loss regrew her hair after taking tofacitinib, with no side effects.

Both treatments for alopecia areata are equally effective and safe.

GLP-1RA therapy may increase the risk of hair loss.

TGPC plus CGT is effective and safe for treating severe alopecia areata in children.

ASLAN004 was safe and well-tolerated, supporting further development for treating certain diseases.

Gefitinib can cause skin problems, diarrhea, and nausea, but rarely causes severe lung disease or hair loss.

Brepocitinib 30mg is most effective for moderate-to-severe alopecia areata, but ritlecitinib 50mg may offer a better balance of safety and effectiveness.

A pancreatic tumor caused high glucagon levels and symptoms, but treatment reduced glucagon and shrank liver tumors.

GLP-1 receptor agonists help with weight loss but need to be combined with other treatments for best results.

TDM10842, a thyroid hormone receptor activator, was found to effectively promote hair growth in mice.

A patient with alopecia areata regrew hair after taking tofacitinib and showed changes in certain blood and skin markers.

The document concludes that understanding genetic mutations in the PI3K-AKT-mTOR pathway can lead to better diagnosis and treatment for certain genetic skin disorders.

Tofacitinib improved arthritis and partially improved hair loss in a lupus patient without side effects.

Ritlecitinib effectively regrows and maintains scalp, eyebrow, and eyelash hair in alopecia areata patients.

Lysocellin helps stop cell damage from etoposide and may prevent hair loss.

Monitoring TGF-β and linc-PINT expression may help identify and treat high-risk heart arrhythmia patients.

Tofacitinib helped regrow hair in a lupus patient with alopecia.

Severe insulin resistance can be managed with medication, lifestyle changes, and treatment for related conditions.

More research is needed to understand if GLP-1 agonists affect hair health.

A man with severe hair loss regrew all his hair using tofacitinib and stayed healthy for a year.

The new chemotherapy combination for advanced lung cancer showed a 35.7% response rate but caused significant side effects.

Ritlecitinib effectively promotes hair regrowth in severe and very severe alopecia areata.

Deuruxolitinib effectively improves hair regrowth in alopecia areata but requires monitoring for side effects.

Selumetinib causes fewer and less severe skin issues in children than binimetinib.

Type 2 diabetes in youth is increasing, with high treatment failure rates and more severe than Type 1; certain drugs can lower lipid levels effectively with varying side effects, and apples may benefit heart health like statins but with fewer side effects.

Ritlecitinib effectively treats alopecia areata in patients 12 and older with fewer side effects.

Tofacitinib helped a woman with total-body hair loss grow her hair back.

Vismodegib effectively treats advanced basal cell carcinoma but requires careful management of serious side effects.